Clinical year in review

Year in review
Aims: To provide an overview of the most relevant advances in diagnosis and treatment of some of the most prevalent respiratory diseases; to present the most important studies published in the last 12 months about clinical aspects of COVID-19, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.

COVID-19: impact on respiratory patients and prevention M. Bafadhel (Oxford (Oxfordshire), United Kingdom)
COPD: implementing biomarkers to improve prognosis M. Barrecheguren Fernandez (Barcelona, Spain)
Severe asthma: classification and treatment G. Brusselle (Ghent, Belgium)
Interstitial lung disease: improving classification and prognosis L. Richeldi (Roma, Italy)